One of the objectives of the LIFE MILCH project is to sign agreements to reduce endocrine disruptors from commercial products. Excellent results were achieved after the first Focus Group, titled "An alliance for a commitment to the reduction of EDs," organized by Dr. Cinzia Zugolaro on October 25th, as part of the 21st Neonatology and Pediatrics Workshop at the University of Cagliari. The first five agreements have been signed. The smart companies are Azolea, Asinus Atlantic, Buona Spa Società Benefit, Epinutracell Srl, and the Azores Trading Company. The entire partnership is very satisfied with the results achieved. A second Focus Group is scheduled for November 28th in Parma, as part of the 7th Conference "Environment, Diabetes, and Endocrine Disorders in Pediatrics".